Clinical importance of pharmacogenetic polymorphisms affecting drug metabolism Part II. Internal medicine /
Saved in:
Other Authors: | Stingl, Julia (Speaker) |
---|---|
Format: | Electronic Video |
Language: | English |
Published: |
London :
Henry Stewart Talks,
2016.
|
Series: | Henry Stewart talks. Biomedical & life sciences collection. Drug metabolizing enzymes : fundamentals, study methods, recent advances and clinical significance.
|
Subjects: | |
Online Access: | https://hstalks.com/bs/698/ Series |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical importance of pharmacogenetic polymorphisms affecting drug metabolism Part II. Internal medicine /
Published: (2016) -
Clinical importance of pharmacogenetic polymorphisms affecting drug metabolism Part II. Internal medicine /
Published: (2016) -
Clinical significance of enzyme induction and inhibition
Published: (2016) -
Why study the cytochrome P4503A (CYP3A) family ?
Published: (2007) -
Genetic variability in paraoxonase 1 (PON1), an HDL associated esterase impact on risk and pharmacokinetics /
Published: (2007)